170
Participants
Start Date
May 22, 2019
Primary Completion Date
October 31, 2023
Study Completion Date
January 31, 2026
IPH4102
Patients will receive a flat dose of 750mg
Institut Jules Bordet, Brussels
Medizinische Universitaet Wien, Vienna
UZ Leuven - campus Gasthuisberg, Leuven
Centre Hospitalier Universitaire (CHU) de Liege, Liège
Columbia University Department of Dermatology, New York
Charite - Universitaetsmedizin Berlin, Berlin
Universita di Torino, Ospedale le Molinette, Turin
Institut Paoli-Calmettes, Marseille
Universal Dermatology, PLLC68, Fairport
University of Pittsburgh School of Medicine, Pittsburgh
University of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
Inova Health Care Services, Fairfax
Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel
ASST degli Spedali Civili di Brescia, Brescia
Hospital Universitario 12 de Octubre, Madrid
IUCT Oncopôle, Toulouse
Johannes Wesling Klinikum Minden, Minden
CHU de Bordeaux Saint André, Bordeaux
Moffitt Cancer Center, Tampa
University of South Florida, Tampa
CHRU de Montpellier - Hopital Saint Eloi, Montpellier
University of Alabama at Birmingham, Birmingham
Hospital Clinico Universitario de Salamanca, Salamanca
CHRU de Tours, Hôpital Trousseau, Chambray-lès-Tours
"Institute of Hematology Seràgnoli, Univeristy of Bologna", Bologna
Ruhr-University Bochum, Bochum
Consorci Hospital General Universitari de Valencia Servicio de Dermatología, Valencia
Hospital Universitari i Politecnic La Fe, Valencia
Universitaetsklinikum Muenster, Münster
CHRU de Lille - Hopital Claude Huriez, Lille
Universitätsklinikum Frankfurt, Frankfurt
Northwestern University The Feinberg School of Medicine, Chicago
Washington University School of Medicine, St Louis
Universitaetsmedizin Mannheim GmbH, Mannheim
Centre Hospitalier Lyon-Sud, Lyon
Hôpital Saint-Louis, Paris
Hôpital Charles Nicolle-CHU de Rouen Clinique Dermatologie, Rouen
University of California, Los Angeles (UCLA) - Medical Center, Los Angeles
Irvine Medical Center, Orange
CHU Henri Mondor, Créteil
Stanford University, Stanford
Dana-Farber Cancer Institute, Boston
Dartmouth Hitchcock Medical Center, Lebanon
MD Anderson Cancer Center, Houston
Universitätsklinik für Dermatologie Medizinische Universität Graz, Graz
Universitaetsklinikum Halle (Saale), Halle
Istituto Dermopatico dell'Immacolata (IDI-IRCCS), Roma
Uniwersyteckie Centrum Kliniczne, Klinika Dermatologii, Wenerologii i Alergologii ul. Smoluchowskiego 17, Gdansk
CET Centrum Medyczne Pratia Poznan ul. Poznanska 14, Skorzewo
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Klinika Nowotworow Ukladu Chlonnego, Warsaw
Hospital del Mar, Barcelona
Hospital Clinic Barcelona, Barcelona
Lead Sponsor
Innate Pharma
INDUSTRY